-
In many tumors this process appears to go into hyperdrive.
FORBES: Health
-
These have been well known for years to be crucial gene defects in many common tumors.
FORBES: Gleevec Inventor: Why Aren't There More Cancer Cures?
-
This suggests that the current study, which used people's recollections of phone usage, underestimates the risk of tumors in many users, he said.
CNN: Study fails to end debate on cancer, cell phone link
-
He says the reason why so many cancer drugs are fizzling in trials is that common tumors contain too many mutations for targeted drugs to work.
FORBES: Pfizer Fights Back Against
-
In many cases MTOR drugs don't shrink tumors much but merely blunt their growth.
FORBES: Magazine Article
-
As many as ten tumors can be targeted in one session.
FORBES: Three New Cancer Drugs You Should Watch
-
In a study conducted with many patients in Japan, 28% of non-small cell lung cancer patients saw their tumors shrink with Iressa, compared with 10% of Caucasians.
FORBES: Pharmaceuticals
-
Other brain cancer cells, by contrast, were incapable of forming new tumors, no matter how many were injected into the mice, Dirks wrote last month in the journal Nature.
FORBES: Cancer Killer